Literature DB >> 20479776

Inferring relevant control mechanisms for interleukin-12 signaling in naïve CD4+ T cells.

Stacey D Finley1, Deepti Gupta, Ning Cheng, David J Klinke.   

Abstract

Interleukin-12 (IL-12) is a key cytokine involved in shaping the cell-mediated immunity to intracellular pathogens. IL-12 initiates a cellular response through the IL-12 signaling pathway, a member of the Janus kinase/signal transducer and activator of transcription (JAK/STAT) family of signaling networks. The JAK/STAT pathway includes several regulatory elements; however, the dynamics of these mechanisms are not fully understood. Therefore, the objective of this study was to infer the relative importance of regulatory mechanisms that modulate the activation of STAT4 in naïve CD4(+) T cells. Dynamic changes in protein expression and activity were measured using flow cytometry and these data were used to calibrate a mathematical model of IL-12 signaling. An empirical Bayesian approach was used to infer the relative strengths of the different regulatory mechanisms in the system. The model predicted that IL-12 receptor expression is regulated by a dynamic, autonomous program that was independent of STAT4 activation. In summary, a mathematical model of the canonical IL-12 signaling pathway used in conjunction with a Bayesian framework provided high-confidence predictions of the system-specific control mechanisms from the available experimental observations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20479776      PMCID: PMC3004982          DOI: 10.1038/icb.2010.69

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  48 in total

Review 1.  Assembly of cell regulatory systems through protein interaction domains.

Authors:  Tony Pawson; Piers Nash
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

2.  Sustained IL-12 signaling is required for Th1 development.

Authors:  Veronica Athie-Morales; Hermelijn H Smits; Doreen A Cantrell; Catharien M U Hilkens
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

3.  Dynamics of the p53-Mdm2 feedback loop in individual cells.

Authors:  Galit Lahav; Nitzan Rosenfeld; Alex Sigal; Naama Geva-Zatorsky; Arnold J Levine; Michael B Elowitz; Uri Alon
Journal:  Nat Genet       Date:  2004-01-18       Impact factor: 38.330

Review 4.  Heterogeneity of cytokine secretion patterns and functions of helper T cells.

Authors:  T R Mosmann; R L Coffman
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

5.  Oscillations in transcription factor dynamics: a new way to control gene expression.

Authors:  D E Nelson; V Sée; G Nelson; M R H White
Journal:  Biochem Soc Trans       Date:  2004-12       Impact factor: 5.407

Review 6.  Th17 cell induction and immune regulatory effects.

Authors:  Yujing Bi; Guangwei Liu; Ruifu Yang
Journal:  J Cell Physiol       Date:  2007-05       Impact factor: 6.384

7.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation.

Authors:  Alexander Hoffmann; Andre Levchenko; Martin L Scott; David Baltimore
Journal:  Science       Date:  2002-11-08       Impact factor: 47.728

Review 8.  The JAK-STAT signaling pathway: input and output integration.

Authors:  Peter J Murray
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

9.  Identification of a nuclear Stat1 protein tyrosine phosphatase.

Authors:  Johanna ten Hoeve; Maria de Jesus Ibarra-Sanchez; Yubin Fu; Wei Zhu; Michel Tremblay; Michael David; Ke Shuai
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

10.  Early target genes of IL-12 and STAT4 signaling in th cells.

Authors:  Riikka J Lund; Zhi Chen; Joonas Scheinin; Riitta Lahesmaa
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

View more
  15 in total

1.  Timescale analysis of rule-based biochemical reaction networks.

Authors:  David J Klinke; Stacey D Finley
Journal:  Biotechnol Prog       Date:  2011-09-26

2.  A quantitative systems approach to identify paracrine mechanisms that locally suppress immune response to Interleukin-12 in the B16 melanoma model.

Authors:  Yogesh M Kulkarni; Emily Chambers; A J Robert McGray; Jason S Ware; Jonathan L Bramson; David J Klinke
Journal:  Integr Biol (Camb)       Date:  2012-07-09       Impact factor: 2.192

3.  Melanoma exosomes deliver a complex biological payload that upregulates PTPN11 to suppress T lymphocyte function.

Authors:  Yueting Wu; Wentao Deng; Emily Chambers McGinley; David J Klinke
Journal:  Pigment Cell Melanoma Res       Date:  2017-03-07       Impact factor: 4.693

4.  Quantifying crosstalk among interferon-γ, interleukin-12, and tumor necrosis factor signaling pathways within a TH1 cell model.

Authors:  David J Klinke; Ning Cheng; Emily Chambers
Journal:  Sci Signal       Date:  2012-04-17       Impact factor: 8.192

5.  In silico model-based inference: an emerging approach for inverse problems in engineering better medicines.

Authors:  David J Klinke; Marc R Birtwistle
Journal:  Curr Opin Chem Eng       Date:  2015-11-01       Impact factor: 5.163

6.  Target-mediated disposition model describing the dynamics of IL12 and IFNγ after administration of a mifepristone-inducible adenoviral vector for IL-12 expression in mice.

Authors:  Zinnia Patricia Parra-Guillen; Alvaro Janda; Pilar Alzuguren; Pedro Berraondo; Ruben Hernandez-Alcoceba; Iñaki F Troconiz
Journal:  AAPS J       Date:  2012-11-08       Impact factor: 4.009

Review 7.  Understanding immunology via engineering design: the role of mathematical prototyping.

Authors:  David J Klinke; Qing Wang
Journal:  Comput Math Methods Med       Date:  2012-09-03       Impact factor: 2.238

Review 8.  A multiscale systems perspective on cancer, immunotherapy, and Interleukin-12.

Authors:  David J Klinke
Journal:  Mol Cancer       Date:  2010-09-15       Impact factor: 27.401

Review 9.  Enhancing the discovery and development of immunotherapies for cancer using quantitative and systems pharmacology: Interleukin-12 as a case study.

Authors:  David J Klinke
Journal:  J Immunother Cancer       Date:  2015-06-16       Impact factor: 13.751

10.  Optimal experiment design for model selection in biochemical networks.

Authors:  Joep Vanlier; Christian A Tiemann; Peter A J Hilbers; Natal A W van Riel
Journal:  BMC Syst Biol       Date:  2014-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.